Who
Yang Li
Exec. Vice President, Research
Company insider
Files Form 4 as: Exec. Vice President, Research, Surrozen.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $165K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Dec 2023
- Last trade
- 15 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 16 Jun 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code A | $14K1,666 at $8.11 | filing |
| 15 Jun 2026filed 16 Jun 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code A | $14K1,666 at $8.11 | filing |
| 4 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $53K1,584 at $33.33 | filing |
| 4 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $53K1,584 at $33.33 | filing |
| 1 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —4,375 | filing |
| 1 May 2026filed 5 May 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,375 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,375 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —4,375 | filing |
| 31 Mar 2026filed 1 Apr 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code G | —1,666 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code G | —1,666 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,950 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,950 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,950 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,950 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $22K1,118 at $19.87 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $22K1,118 at $19.87 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —2,500 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —2,500 | filing |
News
With direct delivery to Pyongyang limited, US litigants turn to North Korea's UN missionvoanews.com · 20 Oct 2026Venerable Yang Li's Ceramic Artwork "Huihu" Debuts in Genevaopenpr.com · 21 Sep 2026NEW MOSCOW-PYONGYANG LINK: Russia And North Korea Open First Road Bridgetheyeshivaworld.com · 8 Sep 2026Head to Head Review: Surrozen (NASDAQ:SRZN) vs. AbCellera Biologics (NASDAQ:ABCL)SRZN · tickerreport.com · 14 Oct 2026Surrozen Sees Unusually Large Options Volume (NASDAQ:SRZN)SRZN · themarketsdaily.com · 12 Oct 2026
3 headlines in the last 90 days name Yang Li; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.